Cash flow AddLife AB

Equities

ALIF B

SE0014401378

Medical Equipment, Supplies & Distribution

Real-time Estimate Cboe Europe Other stock markets 07:11:40 12/03/26 pm AEDT			5-day change	1st Jan Change
140.60 ^SEK	-1.26%		-3.65%	-10.50%

06:21pm	Addlife acquires British firm BioSpectrum	FW
11/03	Odin Sverige rose 4.16 percent in February - increased exposure to smaller companies	FW

5b41c292cf27f0562f023e.VYk98DGKNBmWHHpq3QaPUzJ8G6mVvL1UBebx8ufmSPk.Gft_p0jccFv_RjgDtkX2EWodecPB1opmUJ_Cy4zXEMAG_l-kALNBT9BSGQ

Published financial data: ADDLIFE AB

Annual

Quarterly

Halfyear

YTD

LTM

Fiscal Period: December	2020	2021	2022	2023	2024
Revenues	5.27B	7.99B	9.08B	9.68B	10.29B
Total Revenues	5.27B	7.99B	9.08B	9.68B	10.29B
Cost of Goods Sold, Total	3.45B	5.14B	5.66B	6.08B	6.43B
Gross Profit	1.82B	2.86B	3.43B	3.6B	3.86B
Selling General & Admin Expenses, Total	1.14B	1.82B	2.66B	3.01B	3.08B
R&D Expenses	23.9M	33.5M	81M	97M	71M
Other Operating Expenses	-16.4M	-42.3M	-35M	-73M	-19M
Other Operating Expenses, Total	1.14B	1.81B	2.7B	3.03B	3.13B
Operating Income	675M	1.05B	725M	569M	727M
Interest Expense, Total	-15.8M	-56.1M	-111M	-273M	-297M
Interest And Investment Income	800K	900K	445M	9M	5M
Net Interest Expenses	-15M	-55.2M	334M	-264M	-292M
Currency Exchange Gains (Loss)	-3.1M	-3.4M	-94M	26M	-7M
Other Non Operating Income (Expenses)	-2.1M	-2.9M	-451M	-9M	-21M
EBT, Excl. Unusual Items	655M	985M	514M	322M	407M
Restructuring Charges	-	-	-	-133M	-10M
Merger & Related Restructuring Charges	-12M	-55.5M	-12M	-	-2M
Gain (Loss) On Sale Of Assets	3.7M	3.3M	3M	3M	6M
Other Unusual Items	12.3M	-5.6M	97M	147M	4M
EBT, Incl. Unusual Items	659M	927M	602M	339M	405M
Income Tax Expense	139M	207M	119M	147M	151M
Earnings From Continuing Operations	520M	721M	483M	192M	254M
Net Income to Company	520M	721M	483M	192M	254M
Minority Interest	-1.9M	-2M	-3M	-2M	-2M
Net Income - (IS)	518M	719M	480M	190M	252M
Net Income to Common Incl Extra Items	518M	719M	480M	190M	252M
Net Income to Common Excl. Extra Items	518M	719M	480M	190M	252M
Per Share Items
Net EPS - Basic	4.62	6.02	3.94	1.56	2.07
Basic EPS - Continuing Operations	4.62	6.02	3.94	1.56	2.07
Basic Weighted Average Shares Outstanding	112M	119M	122M	122M	122M
Net EPS - Diluted	4.6	5.99	3.93	1.56	2.06
Diluted EPS - Continuing Operations	4.6	5.99	3.93	1.56	2.06
Diluted Weighted Average Shares Outstanding	113M	120M	122M	122M	122M
Normalized Basic EPS	3.63	5.14	2.61	1.64	2.07
Normalized Diluted EPS	3.62	5.11	2.6	1.64	2.07
Dividend Per Share	1.5	2	1.2	0.5	0.75
Payout Ratio	10.85	25.47	50.62	76.84	24.21
American Depositary Receipts Ratio (ADR)	1	1	1	1	1
Supplemental Items
EBITDA	834M	1.38B	1.26B	1.16B	1.31B
EBITA	784M	1.3B	1.1B	976M	1.12B
EBIT	675M	1.05B	725M	569M	727M
EBITDAR	835M	1.38B	1.26B	1.17B	1.31B
Effective Tax Rate - (Ratio)	21.14	22.28	19.77	43.36	37.28
Total Current Taxes	151M	247M	211M	183M	191M
Total Deferred Taxes	-12.1M	-40.3M	-92M	-36M	-40M
Normalized Net Income	407M	614M	318M	199M	252M
Interest on Long-Term Debt	2.7M	3.5M	5M	11M	16M
Non-Cash Pension Expense	1.7M	1.6M	1M	2M	2M
Supplemental Operating Expense Items
Selling and Marketing Expenses	862M	1.43B	2.11B	2.42B	2.48B
General and Administrative Expenses	273M	388M	542M	580M	592M
Research And Development Expense From Footnotes	66M	77.3M	133M	226M	129M
Net Rental Expense, Total	1.5M	2M	2M	4M	1M
Imputed Operating Lease Interest Expense	223K	366K	366K	1.61M	459K
Imputed Operating Lease Depreciation	1.28M	1.63M	1.63M	2.39M	541K

Fiscal Period: December	2020	2021	2022	2023	2024
Assets
Cash And Equivalents	216M	345M	376M	272M	331M
Total Cash And Short Term Investments	216M	345M	376M	272M	331M
Accounts Receivable, Total	755M	1.09B	1.35B	1.48B	1.56B
Other Receivables	40.4M	77.7M	133M	117M	214M
Total Receivables	796M	1.17B	1.48B	1.6B	1.78B
Inventory	640M	1.19B	1.65B	1.65B	1.72B
Prepaid Expenses	22M	48M	64M	78M	96M
Other Current Assets, Total	18.6M	1.7M	2M	3M	3M
Total Current Assets	1.69B	2.75B	3.57B	3.61B	3.93B
Gross Property Plant And Equipment	998M	1.65B	2.48B	2.78B	3.1B
Accumulated Depreciation	-564M	-1.02B	-1.58B	-1.73B	-1.96B
Net Property Plant And Equipment	434M	627M	899M	1.05B	1.15B
Long-term Investments	8.8M	8.7M	10M	9M	20M
Goodwill	1.1B	4.53B	5.31B	5.3B	5.54B
Other Intangibles, Total	840M	2.56B	2.99B	2.55B	2.3B
Deferred Tax Assets Long-Term	5M	11.2M	51M	46M	19M
Deferred Charges Long-Term	63.4M	104M	137M	109M	105M
Other Long-Term Assets, Total	7M	7.4M	85M	66M	-
Total Assets	4.15B	10.6B	13.06B	12.74B	13.06B
Liabilities
Accounts Payable, Total	649M	796M	957M	981M	1.1B
Accrued Expenses, Total	205M	300M	397M	431M	458M
Short-term Borrowings	-	454M	746M	440M	212M
Current Portion of Long-Term Debt	473M	2.74B	1.74B	1.81B	591M
Current Portion of Leases	91.2M	121M	131M	157M	176M
Current Income Taxes Payable	81.1M	110M	70M	39M	69M
Unearned Revenue Current, Total	5M	80.3M	90M	73M	85M
Other Current Liabilities	241M	312M	320M	378M	496M
Total Current Liabilities	1.74B	4.91B	4.46B	4.3B	3.18B
Long-Term Debt	99.6M	564M	2.74B	2.54B	3.74B
Long-Term Leases	142M	224M	225M	347M	355M
Pension & Other Post Retirement Benefits	80.5M	81.5M	60M	64M	62M
Deferred Tax Liability Non Current	162M	489M	459M	415M	374M
Other Non Current Liabilities	30.7M	34M	142M	115M	33M
Total Liabilities	2.26B	6.3B	8.09B	7.78B	7.75B
Common Stock, Total	58.3M	62.4M	62M	62M	62M
Additional Paid In Capital	1.13B	2.65B	2.64B	2.64B	2.64B
Retained Earnings	739M	1.55B	1.79B	1.82B	2B
Comprehensive Income and Other	-49.5M	22.1M	477M	435M	602M
Total Common Equity	1.88B	4.29B	4.97B	4.96B	5.31B
Minority Interest	8.2M	5.7M	3M	2M	3M
Total Equity	1.89B	4.29B	4.97B	4.96B	5.31B
Total Liabilities And Equity	4.15B	10.6B	13.06B	12.74B	13.06B
Supplemental Items
ECS Total Shares Outstanding on Filing Date	112M	122M	122M	122M	122M
ECS Total Common Shares Outstanding	112M	122M	122M	122M	122M
Book Value / Share	16.73	35.14	40.78	40.69	43.54
Tangible Book Value	-57.3M	-2.8B	-3.34B	-2.9B	-2.53B
Tangible Book Value Per Share	-0.51	-22.97	-27.37	-23.78	-20.75
Total Debt	806M	4.1B	5.59B	5.29B	5.07B
Net Debt	590M	3.76B	5.22B	5.02B	4.74B
Debt Equivalent of Unfunded Proj. Benefit Obligation	80.5M	81.5M	60M	64M	62M
Debt Equivalent Oper. Leases	12M	16M	16M	32M	8M
Minority Interest, Total (Incl. Fin. Div)	8.2M	5.7M	3M	2M	3M
Account Code - Inventory Valuation	3	3	3	3	3
Inventories - Raw Materials, Total	33.2M	43.3M	61M	54M	53M
Inventories - Work In Process, Total	17.5M	8.3M	7M	15M	10M
Inventories - Finished Goods, Total	590M	1.14B	1.58B	1.58B	1.66B
Buildings, Total	41.8M	43.1M	152M	154M	157M
Machinery, Total	543M	942M	1.6B	1.7B	1.88B
Full Time Employees	1.11K	1.8K	2.22K	2.3K	2.18K
Accumulated Allowance for Doubtful Accounts (Supple)	45.9M	45M	33M	37M	35M

Fiscal Period: December	2020	2021	2022	2023	2024
Net Income	518M	719M	480M	190M	252M
Depreciation & Amortization - CF	144M	201M	310M	350M	374M
Amortization of Goodwill and Intangible Assets - (CF)	109M	250M	378M	407M	397M
Depreciation & Amortization, Total	253M	452M	688M	757M	771M
Amortization of Deferred Charges, Total - (CF)	20.3M	26.7M	35M	37M	41M
(Gain) Loss From Sale Of Asset	-3.7M	-3.3M	-2M	-3M	-6M
Asset Writedown & Restructuring Costs	-	-	-	125M	-
Other Operating Activities, Total	54.6M	-69.9M	-171M	-269M	-7M
Change In Accounts Receivable	-171M	18.3M	64M	-129M	-28M
Change In Inventories	-119M	52.8M	-88M	-30M	-4M
Change in Other Net Operating Assets	397M	-185M	-97M	95M	76M
Cash from Operations	950M	1.01B	909M	773M	1.1B
Capital Expenditure	-62.7M	-101M	-213M	-226M	-250M
Sale of Property, Plant, and Equipment	7.8M	9.3M	13M	22M	16M
Cash Acquisitions	-345M	-2.84B	-818M	-27M	-104M
Divestitures	-	-	-	-4M	-
Sale (Purchase) of Intangible assets	-28.7M	-42.5M	-68M	-82M	-47M
Investment in Marketable and Equity Securities, Total	-	-	-	0	-1M
Cash from Investing	-429M	-2.98B	-1.09B	-317M	-386M
Long-Term Debt Issued, Total	265M	2.65B	1.42B	174M	72M
Total Debt Issued	265M	2.65B	1.42B	174M	72M
Long-Term Debt Repaid, Total	-614M	-260M	-846M	-407M	-678M
Total Debt Repaid	-614M	-260M	-846M	-407M	-678M
Issuance of Common Stock	-	-	-	-	-
Repurchase of Common Stock	-19.3M	-	-60M	-	-
Common Dividends Paid	-56.2M	-183M	-243M	-146M	-61M
Common & Preferred Stock Dividends Paid	-56.2M	-183M	-243M	-146M	-61M
Other Financing Activities, Total	52.2M	-136M	-133M	-175M	-15M
Cash from Financing	-372M	2.07B	134M	-554M	-682M
Foreign Exchange Rate Adjustments	-32M	26.1M	74M	-6M	32M
Net Change in Cash	117M	129M	31M	-104M	59M
Supplemental Items
Cash Interest Paid	13.1M	52.6M	53M	272M	322M
Cash Income Tax Paid (Refund)	97M	252M	256M	210M	137M
Levered Free Cash Flow	667M	442M	273M	599M	826M
Unlevered Free Cash Flow	677M	477M	342M	770M	1.01B
Change In Net Working Capital	-72.3M	511M	553M	72M	-42M
Net Debt Issued / Repaid	-349M	2.39B	570M	-233M	-606M

Fiscal Period: December	2020	2021	2022	2023	2024
Profitability
Return on Assets	11.37	8.87	3.83	2.76	3.52
Return on Total Capital	16.65	11.8	4.78	3.42	4.41
Return On Equity %	30.87	23.32	10.43	3.87	4.95
Return on Common Equity	30.92	23.3	10.38	3.83	4.91
Margin Analysis
Gross Profit Margin %	34.48	35.74	37.73	37.17	37.52
SG&A Margin	21.54	22.76	29.24	31.05	29.94
EBITDA Margin %	15.81	17.22	13.86	12	12.76
EBITA Margin %	14.87	16.22	12.14	10.08	10.93
EBIT Margin %	12.8	13.09	7.98	5.88	7.07
Income From Continuing Operations Margin %	9.86	9.02	5.32	1.98	2.47
Net Income Margin %	9.82	8.99	5.28	1.96	2.45
Net Avail. For Common Margin %	9.82	8.99	5.28	1.96	2.45
Normalized Net Income Margin	7.73	7.68	3.5	2.06	2.45
Levered Free Cash Flow Margin	12.64	5.53	3	6.18	8.03
Unlevered Free Cash Flow Margin	12.83	5.97	3.77	7.95	9.83
Asset Turnover
Asset Turnover	1.42	1.08	0.77	0.75	0.8
Fixed Assets Turnover	13.41	15.07	11.91	9.93	9.36
Receivables Turnover (Average Receivables)	8.18	8.67	7.45	6.83	6.75
Inventory Turnover (Average Inventory)	6.33	5.62	3.99	3.69	3.81
Short Term Liquidity
Current Ratio	0.97	0.56	0.8	0.84	1.23
Quick Ratio	0.58	0.31	0.42	0.44	0.66
Operating Cash Flow to Current Liabilities	0.54	0.21	0.2	0.18	0.34
Days Sales Outstanding (Average Receivables)	44.73	42.1	49.02	53.44	54.19
Days Outstanding Inventory (Average Inventory)	57.83	64.98	91.46	98.94	96.16
Average Days Payable Outstanding	49.99	46.39	52.33	58.06	58.55
Cash Conversion Cycle (Average Days)	52.57	60.69	88.15	94.33	91.8
Long Term Solvency
Total Debt/Equity	42.63	95.6	112.47	106.63	95.52
Total Debt / Total Capital	29.89	48.88	52.94	51.6	48.85
LT Debt/Equity	12.78	18.36	59.73	58.19	77.08
Long-Term Debt / Total Capital	8.96	9.39	28.11	28.16	39.42
Total Liabilities / Total Assets	54.45	59.5	61.93	61.08	59.33
EBIT / Interest Expense	42.73	18.65	6.53	2.08	2.45
EBITDA / Interest Expense	58.77	26.71	12.73	4.86	5.04
(EBITDA - Capex) / Interest Expense	54.8	24.9	10.81	4.03	4.2
Total Debt / EBITDA	0.87	2.74	3.96	3.99	3.39
Net Debt / EBITDA	0.64	2.51	3.69	3.78	3.16
Total Debt / (EBITDA - Capex)	0.93	2.94	4.66	4.81	4.06
Net Debt / (EBITDA - Capex)	0.68	2.69	4.35	4.56	3.8
Growth Over Prior Year
Total Revenues, 1 Yr. Growth %	51.56	51.57	13.65	6.62	6.21
Gross Profit, 1 Yr. Growth %	51.76	57.09	19.95	5.05	7.19
EBITDA, 1 Yr. Growth %	165.99	65.12	-8.44	-7.7	13.01
EBITA, 1 Yr. Growth %	184.4	65.3	-14.89	-11.51	15.16
EBIT, 1 Yr. Growth %	266.96	54.99	-30.69	-21.52	27.77
Earnings From Cont. Operations, 1 Yr. Growth %	265.21	38.66	-33.01	-60.25	32.29
Net Income, 1 Yr. Growth %	268.28	38.78	-33.24	-60.42	32.63
Normalized Net Income, 1 Yr. Growth %	288.81	50.59	-48.14	-37.39	26.66
Diluted EPS Before Extra, 1 Yr. Growth %	263.85	30.32	-34.49	-60.29	32.12
Accounts Receivable, 1 Yr. Growth %	41.5	44.17	24.06	9.92	5.12
Inventory, 1 Yr. Growth %	41.79	85.65	38.44	0.43	4.3
Net Property, Plant and Equip., 1 Yr. Growth %	22.94	44.65	43.38	16.91	9.13
Total Assets, 1 Yr. Growth %	26.73	155.34	23.23	-2.39	2.43
Tangible Book Value, 1 Yr. Growth %	-75.98	4.79K	19.02	-13.1	-12.73
Common Equity, 1 Yr. Growth %	28.3	127.68	15.94	-0.2	7.02
Cash From Operations, 1 Yr. Growth %	137.29	6.33	-10	-14.96	41.66
Capital Expenditures, 1 Yr. Growth %	-4.57	61.72	110.89	6.1	10.62
Levered Free Cash Flow, 1 Yr. Growth %	257.01	-33.68	-38.06	119.62	37.85
Unlevered Free Cash Flow, 1 Yr. Growth %	249.66	-29.46	-28.03	124.95	31.41
Dividend Per Share, 1 Yr. Growth %	200	33.33	-40	-58.33	50
Compound Annual Growth Rate Over Two Years
Total Revenues, 2 Yr. CAGR %	45.77	51.56	31.25	10.08	6.41
Gross Profit, 2 Yr. CAGR %	42.95	54.4	37.28	12.25	6.12
EBITDA, 2 Yr. CAGR %	82.64	109.57	22.89	-8.07	2.08
EBITA, 2 Yr. CAGR %	85.49	116.88	18.57	-13.22	0.95
EBIT, 2 Yr. CAGR %	101.98	138.48	3.62	-26.25	0.14
Earnings From Cont. Operations, 2 Yr. CAGR %	100.48	125.03	-3.6	-48.4	-27.48
Net Income, 2 Yr. CAGR %	100.12	126.07	-3.72	-48.59	-27.54
Normalized Net Income, 2 Yr. CAGR %	103.13	141.98	-11.62	-43.02	-10.95
Diluted EPS Before Extra, 2 Yr. CAGR %	85.19	117.75	-7.58	-48.99	-27.57
Accounts Receivable, 2 Yr. CAGR %	21.95	42.83	33.75	16.77	7.49
Inventory, 2 Yr. CAGR %	25.22	62.24	60.35	17.91	2.34
Net Property, Plant and Equip., 2 Yr. CAGR %	98.36	33.35	43.99	29.47	12.95
Total Assets, 2 Yr. CAGR %	24.72	79.89	77.39	9.67	-0.01
Tangible Book Value, 2 Yr. CAGR %	-65.49	242.66	662.91	1.7	-12.92
Common Equity, 2 Yr. CAGR %	42.21	70.92	62.47	7.57	3.35
Cash From Operations, 2 Yr. CAGR %	131.36	58.84	-2.19	-12.52	9.76
Capital Expenditures, 2 Yr. CAGR %	43.38	24.23	84.31	49.59	8.34
Levered Free Cash Flow, 2 Yr. CAGR %	433.78	53.88	-36.04	16.63	74
Unlevered Free Cash Flow, 2 Yr. CAGR %	402.11	57.05	-28.89	27.24	71.93
Dividend Per Share, 2 Yr. CAGR %	65.14	100	-10.56	-50	-20.94
Compound Annual Growth Rate Over Three Years
Total Revenues, 3 Yr. CAGR %	31.23	47.68	37.7	22.46	8.77
Gross Profit, 3 Yr. CAGR %	29.31	47.52	41.95	25.57	10.54
EBITDA, 3 Yr. CAGR %	52.14	76.6	58.97	11.71	-1.55
EBITA, 3 Yr. CAGR %	53.45	78.53	58.75	7.55	-4.64
EBIT, 3 Yr. CAGR %	61.4	84.92	57.95	-5.54	-11.42
Earnings From Cont. Operations, 3 Yr. CAGR %	62.87	77.3	50.28	-28.25	-29.37
Net Income, 3 Yr. CAGR %	62.67	77.13	50.57	-28.41	-29.49
Normalized Net Income, 3 Yr. CAGR %	64.15	83.85	44.81	-21.22	-25.63
Diluted EPS Before Extra, 3 Yr. CAGR %	54.97	64.72	45.93	-30.26	-29.95
Accounts Receivable, 3 Yr. CAGR %	31.28	28.95	36.29	25.28	12.75
Inventory, 3 Yr. CAGR %	33.18	42.78	53.91	37.19	13.18
Net Property, Plant and Equip., 3 Yr. CAGR %	79.72	78.54	36.6	34.33	22.3
Total Assets, 3 Yr. CAGR %	29.94	58.36	58.58	45.36	7.2
Tangible Book Value, 3 Yr. CAGR %	-45.5	79.92	140.88	269.81	-3.36
Common Equity, 3 Yr. CAGR %	36.01	66.36	50.17	38.11	7.38
Cash From Operations, 3 Yr. CAGR %	65.92	78.54	31.43	-6.65	2.73
Capital Expenditures, 3 Yr. CAGR %	13.48	49.25	48	53.33	35.27
Levered Free Cash Flow, 3 Yr. CAGR %	66.86	166.36	13.46	-3.51	23.32
Unlevered Free Cash Flow, 3 Yr. CAGR %	66.13	161.02	20.92	4.39	28.62
Dividend Per Share, 3 Yr. CAGR %	39.71	53.78	33.89	-30.66	-27.89
Compound Annual Growth Rate Over Five Years
Total Revenues, 5 Yr. CAGR %	-	32.75	31.24	31.3	24.21
Gross Profit, 5 Yr. CAGR %	-	33.63	32.44	32.25	26.35
EBITDA, 5 Yr. CAGR %	-	47.87	39.69	35.98	33.16
EBITA, 5 Yr. CAGR %	-	48.93	38.43	33.76	32.45
EBIT, 5 Yr. CAGR %	-	49.29	35.18	28.02	31.63
Earnings From Cont. Operations, 5 Yr. CAGR %	-	45.11	32.05	8.23	12.29
Net Income, 5 Yr. CAGR %	-	45.03	31.88	8	12.38
Normalized Net Income, 5 Yr. CAGR %	-	47.84	28.14	15.07	19.22
Diluted EPS Before Extra, 5 Yr. CAGR %	-	37.47	26.03	3.07	10.27
Accounts Receivable, 5 Yr. CAGR %	-	27.3	32.26	23.94	23.94
Inventory, 5 Yr. CAGR %	-	36.33	43.45	32.27	30.73
Net Property, Plant and Equip., 5 Yr. CAGR %	-	56.04	64.47	56.99	26.6
Total Assets, 5 Yr. CAGR %	-	46.38	47.17	36.72	31.86
Tangible Book Value, 5 Yr. CAGR %	-	88.28	56.62	43.22	60.35
Common Equity, 5 Yr. CAGR %	-	42.99	46.03	39.73	29.32
Cash From Operations, 5 Yr. CAGR %	-	50.1	34.31	34.21	22.29
Capital Expenditures, 5 Yr. CAGR %	-	17.08	37.78	49.27	30.64
Levered Free Cash Flow, 5 Yr. CAGR %	-	-	13.7	91.27	34.62
Unlevered Free Cash Flow, 5 Yr. CAGR %	-	-	18.31	95.66	39.2
Dividend Per Share, 5 Yr. CAGR %	-	31.95	16.89	-1.89	8.45